Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Orthocell locks in Singaporean regulatory approval in international commercialisation push for nerve repair product
    • News

    Orthocell locks in Singaporean regulatory approval in international commercialisation push for nerve repair product

    Regenerative medicine business Orthocell (ASX: OCC) has nailed down its first international regulatory approval for the group’s nerve repair product known as Remplir. The formal authorisation from the Health Sciences Authority in Singapore allows the company to begin sales in the nation and builds on its existing markets for the product in Australia and New

    Read More
    Public
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture
    • News

    ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture

    Aspiring financial services provider ARC Funds (ASX:ARC) is set to get a lot more public exposure to new investors having acquired a 30% equity stake in ausbiz Capital, the venture launched by financial media company ausbiz Group – operator of the ausbiz news channel.  This strategic partnership marks a significant development for ARC Funds as

    Read More
    Public
  • Apiam appoints Bruce Dixon as Director, strengthening leadership with Greencross expertise
    • News

    Apiam appoints Bruce Dixon as Director, strengthening leadership with Greencross expertise

    One month after making a substantial on-market purchase of shares, accomplished business leader Bruce Dixon has been appointed to the board of Apiam Animal Health (ASX: AHX), an appointment that may draw the attention of both institutional investors and private equity players alike.  Dixon brings over 30 years of leadership experience, most notably as a

    Read More
    Public
  • Income Asset Management flags positive cashflow via strategic platform partnership with Perpetual
    • News

    Income Asset Management flags positive cashflow via strategic platform partnership with Perpetual

    Ambitious fund manager Income Asset Management (ASX: IAM) has flagged the prospect of positive cash flow thanks to a strategic partnership with Perpetual Corporate Trust, which will play a key role in helping IAM improve its underlying business.  Like many smaller financial service businesses, IAM carries high regulatory and operational expenses which meant that even

    Read More
    Public
  • IG data reveals fresh investor confidence following inflation-induced market lull
    • News

    IG data reveals fresh investor confidence following inflation-induced market lull

    New research published from global financial technology company IG reveals positive sentiment from Australian investors following a 2-year pullback in investor confidence, catalysed by cost-of-living pressures that prompted many households to deplete their savings.  IG’s latest survey, the second iteration of A Trader’s Position – reveals traders are optimistic in their outlook about the Australian

    Read More
    Public
  • Elixinol acquires The Healthy Chef and raises capital to seek growth in the wellness products market
    • News

    Elixinol acquires The Healthy Chef and raises capital to seek growth in the wellness products market

    In an attempt to grow their overall wellness business by diversifying their brands, Elixinol Wellness (ASX: EXL) will acquire The Healthy Chef, a premium wellness brand, in a deal expected to accelerate revenue growth and strengthen their position in the clean nutrition sector. The acquisition complements Elixinol’s existing portfolio and marks a significant step towards

    Read More
    Public
  • «
  • ‹
  • 29
  • 30
  • 31
  • 32
  • 33
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.